Pfizer confirms it will supply an additional 40,000 PAXLOVID® (nirmatrelvir tablets and ritonavir tablets) treatment courses to the New Zealand Government, bringing the total to 100,000 PAXLOVID treatment courses in New Zealand for 2022. PAXLOVID ...